Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 19Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Metgluco

PharmaCompass

01

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 91

2019 Revenue in Millions : 93

Growth (%) : -3

blank

02

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 69

2020 Revenue in Millions : 91

Growth (%) : -13

blank

03

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 60

2021 Revenue in Millions : 69

Growth (%) : -13

blank

04

Brand Name : Metgluco

Biguanide Hydrochloride

arrow
AACR Annual meeting
Not Confirmed

05

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2016 Revenue in Millions : 103

2015 Revenue in Millions : 147

Growth (%) : -30

blank

06

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2017 Revenue in Millions : 109

2016 Revenue in Millions : 111

Growth (%) : -2

blank

07

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2018 Revenue in Millions : 92

2017 Revenue in Millions : 98

Growth (%) : -6%

blank

08

Brand Name : Metgluco

Biguanide

arrow
AACR Annual meeting
Not Confirmed

Brand Name : Metgluco

arrow
AACR Annual meeting
Not Confirmed

Biguanide

Main Therapeutic Indication : Diabetes

Currency : USD

2019 Revenue in Millions : 90

2018 Revenue in Millions : 95

Growth (%) : -5

blank